التفاصيل البيبلوغرافية
| العنوان: |
Chitosan Nanoparticles for Intranasal Drug Delivery. |
| المؤلفون: |
Omidian, Hossein, Gill, Erma J., Dey Chowdhury, Sumana, Cubeddu, Luigi X. |
| المصدر: |
Pharmaceutics; Jun2024, Vol. 16 Issue 6, p746, 34p |
| مصطلحات موضوعية: |
INTRANASAL administration, INTRANASAL medication, CHITOSAN, TREATMENT effectiveness, NANOPARTICLES |
| مستخلص: |
This manuscript explores the use of nanostructured chitosan for intranasal drug delivery, targeting improved therapeutic outcomes in neurodegenerative diseases, psychiatric care, pain management, vaccination, and diabetes treatment. Chitosan nanoparticles are shown to enhance brain delivery, improve bioavailability, and minimize systemic side effects by facilitating drug transport across the blood–brain barrier. Despite substantial advancements in targeted delivery and vaccine efficacy, challenges remain in scalability, regulatory approval, and transitioning from preclinical studies to clinical applications. The future of chitosan-based nanomedicines hinges on advancing clinical trials, fostering interdisciplinary collaboration, and innovating in nanoparticle design to overcome these hurdles and realize their therapeutic potential. [ABSTRACT FROM AUTHOR] |
|
Copyright of Pharmaceutics is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder